Nasdaq First North Growth Market is an alternative market, operated by the different exchanges within Nasdaq OMX. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market. All companies whose shares are traded on First North have a certified adviser who monitors the company’s compliance with First North’s rules regarding the disclosure of information to the market and investors.
Selected experience: Professor Harvard-MIT, Brigham and Women’s Hospital and Harvard Medical School. Leads a satellite laboratory at the World Premier International-Advanced Institute for Materials Research at Tohoku University, Japan.
Selected experience: Professor at Wake Forest School of Medicine and is regarded as a leading authority on biomaterials, medical devices, and biocompatibility. Authored and co-authored over 400 technical papers within his field of expertise.
Selected experience: PhD in Microbiology from Harvard Medical School and awarded an American Cancer Society postdoctoral fellowship at the University of California. Received multiple Honors in the field of breast cancer as well as held several position within her field of research.
Selected experience: Chairman of Bayer HealthCare and Tecan Group, CEO of Bayer Diagnostics, executive management positions within Pharmacia, director of Hill-Rom and Supervisory Board member of Fresenius Medical Care